The trademark application BCISE was filed by ASTRAZENECA PHARMACEUTICALS LP, a U.S. corporation (the "Applicant"). The application was published for oppositions on November 11, 2014, and it was registered by office on February 18, 2015 without any oppositions.
The application was filed in English (French was selected as the second language).
The renewal of the trademark was recorded by the office on May 22, 2024.